Report Detail
Global Gene Therapies for Tumor Treatment Market Growth 2019-2024
- RnM3313424 |
- 12 April, 2019 |
- Global |
- 136 Pages |
- LPI(LP Information) |
- Other
Gene therapy is the therapeutic delivery of nucleic acid into a patient's cells as a drug to treat disease. Research in gene therapy for cancer is currently focused in multiple areas, including genetically engineered viruses that directly kill cancer cells, gene transfer to alter the abnormal functioning of cancer cells, and immunotherapy (which includes CAR T-cell therapy), which helps the immune system better find and kill.
According to this study, over the next five years the Gene Therapies for Tumor Treatment market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Gene Therapies for Tumor Treatment business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Gene Therapies for Tumor Treatment market by product type, application, key manufacturers and key regions and countries.
This study considers the Gene Therapies for Tumor Treatment value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Gene Induced Immunotherapy
Oncolytic Virotherapy
Gene Transfer
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Clinic
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Novartis
Kite Pharma
Amgen
Shanghai Sunway
Sibiono
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Gene Therapies for Tumor Treatment consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Gene Therapies for Tumor Treatment market by identifying its various subsegments.
Focuses on the key global Gene Therapies for Tumor Treatment manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Gene Therapies for Tumor Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Gene Therapies for Tumor Treatment submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Gene Therapies for Tumor Treatment Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Gene Therapies for Tumor Treatment Consumption 2014-2024
- 2.1.2 Gene Therapies for Tumor Treatment Consumption CAGR by Region
- 2.2 Gene Therapies for Tumor Treatment Segment by Type
- 2.2.1 Gene Induced Immunotherapy
- 2.2.2 Oncolytic Virotherapy
- 2.2.3 Gene Transfer
- 2.3 Gene Therapies for Tumor Treatment Consumption by Type
- 2.3.1 Global Gene Therapies for Tumor Treatment Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Gene Therapies for Tumor Treatment Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Gene Therapies for Tumor Treatment Sale Price by Type (2014-2019)
- 2.4 Gene Therapies for Tumor Treatment Segment by Application
- 2.4.1 Hospital
- 2.4.2 Clinic
- 2.4.3 Other
- 2.5 Gene Therapies for Tumor Treatment Consumption by Application
- 2.5.1 Global Gene Therapies for Tumor Treatment Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Gene Therapies for Tumor Treatment Value and Market Share by Application (2014-2019)
- 2.5.3 Global Gene Therapies for Tumor Treatment Sale Price by Application (2014-2019)
3 Global Gene Therapies for Tumor Treatment by Players
- 3.1 Global Gene Therapies for Tumor Treatment Sales Market Share by Players
- 3.1.1 Global Gene Therapies for Tumor Treatment Sales by Players (2017-2019)
- 3.1.2 Global Gene Therapies for Tumor Treatment Sales Market Share by Players (2017-2019)
- 3.2 Global Gene Therapies for Tumor Treatment Revenue Market Share by Players
- 3.2.1 Global Gene Therapies for Tumor Treatment Revenue by Players (2017-2019)
- 3.2.2 Global Gene Therapies for Tumor Treatment Revenue Market Share by Players (2017-2019)
- 3.3 Global Gene Therapies for Tumor Treatment Sale Price by Players
- 3.4 Global Gene Therapies for Tumor Treatment Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Gene Therapies for Tumor Treatment Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Gene Therapies for Tumor Treatment Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Gene Therapies for Tumor Treatment by Regions
- 4.1 Gene Therapies for Tumor Treatment by Regions
- 4.1.1 Global Gene Therapies for Tumor Treatment Consumption by Regions
- 4.1.2 Global Gene Therapies for Tumor Treatment Value by Regions
- 4.2 Americas Gene Therapies for Tumor Treatment Consumption Growth
- 4.3 APAC Gene Therapies for Tumor Treatment Consumption Growth
- 4.4 Europe Gene Therapies for Tumor Treatment Consumption Growth
- 4.5 Middle East & Africa Gene Therapies for Tumor Treatment Consumption Growth
5 Americas
- 5.1 Americas Gene Therapies for Tumor Treatment Consumption by Countries
- 5.1.1 Americas Gene Therapies for Tumor Treatment Consumption by Countries (2014-2019)
- 5.1.2 Americas Gene Therapies for Tumor Treatment Value by Countries (2014-2019)
- 5.2 Americas Gene Therapies for Tumor Treatment Consumption by Type
- 5.3 Americas Gene Therapies for Tumor Treatment Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Gene Therapies for Tumor Treatment Consumption by Countries
- 6.1.1 APAC Gene Therapies for Tumor Treatment Consumption by Countries (2014-2019)
- 6.1.2 APAC Gene Therapies for Tumor Treatment Value by Countries (2014-2019)
- 6.2 APAC Gene Therapies for Tumor Treatment Consumption by Type
- 6.3 APAC Gene Therapies for Tumor Treatment Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Gene Therapies for Tumor Treatment by Countries
- 7.1.1 Europe Gene Therapies for Tumor Treatment Consumption by Countries (2014-2019)
- 7.1.2 Europe Gene Therapies for Tumor Treatment Value by Countries (2014-2019)
- 7.2 Europe Gene Therapies for Tumor Treatment Consumption by Type
- 7.3 Europe Gene Therapies for Tumor Treatment Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Gene Therapies for Tumor Treatment by Countries
- 8.1.1 Middle East & Africa Gene Therapies for Tumor Treatment Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Gene Therapies for Tumor Treatment Value by Countries (2014-2019)
- 8.2 Middle East & Africa Gene Therapies for Tumor Treatment Consumption by Type
- 8.3 Middle East & Africa Gene Therapies for Tumor Treatment Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Gene Therapies for Tumor Treatment Distributors
- 10.3 Gene Therapies for Tumor Treatment Customer
11 Global Gene Therapies for Tumor Treatment Market Forecast
- 11.1 Global Gene Therapies for Tumor Treatment Consumption Forecast (2019-2024)
- 11.2 Global Gene Therapies for Tumor Treatment Forecast by Regions
- 11.2.1 Global Gene Therapies for Tumor Treatment Forecast by Regions (2019-2024)
- 11.2.2 Global Gene Therapies for Tumor Treatment Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Gene Therapies for Tumor Treatment Forecast by Type
- 11.8 Global Gene Therapies for Tumor Treatment Forecast by Application
12 Key Players Analysis
- 12.1 Novartis
- 12.1.1 Company Details
- 12.1.2 Gene Therapies for Tumor Treatment Product Offered
- 12.1.3 Novartis Gene Therapies for Tumor Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Novartis News
- 12.2 Kite Pharma
- 12.2.1 Company Details
- 12.2.2 Gene Therapies for Tumor Treatment Product Offered
- 12.2.3 Kite Pharma Gene Therapies for Tumor Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Kite Pharma News
- 12.3 Amgen
- 12.3.1 Company Details
- 12.3.2 Gene Therapies for Tumor Treatment Product Offered
- 12.3.3 Amgen Gene Therapies for Tumor Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Amgen News
- 12.4 Shanghai Sunway
- 12.4.1 Company Details
- 12.4.2 Gene Therapies for Tumor Treatment Product Offered
- 12.4.3 Shanghai Sunway Gene Therapies for Tumor Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Shanghai Sunway News
- 12.5 Sibiono
- 12.5.1 Company Details
- 12.5.2 Gene Therapies for Tumor Treatment Product Offered
- 12.5.3 Sibiono Gene Therapies for Tumor Treatment Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Sibiono News
...
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Gene Therapies for Tumor Treatment . Industry analysis & Market Report on Gene Therapies for Tumor Treatment is a syndicated market report, published as Global Gene Therapies for Tumor Treatment Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Gene Therapies for Tumor Treatment market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
